Milam Brantley is an Ophthalmology physician affiliated with Vanderbilt Health. OpenAlex indexes 122 publications with 4,856 citations (h-index 31).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3601 Tvc
Nashville, TN 372320001
Telephone
615-322-3000Provider last certified this registry record 22 Mar 2022.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Salix Pharmaceuticals, a division of Bausch Health US, LLCProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
93.7%Vascular Endothelial Growth Factor Inhibitor93.7%Bevacizumab72%Aflibercept28%Part B, office-administered≥94 patientsMusculoskeletal
3.2%Cyclooxygenase Inhibitor3.2%Ketorolac Tromethamine100%Part D<11 patientsSensory organs
3.1%Corticosteroid3.1%Prednisolone Acetate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2013–2023 per NIH RePORTER. The latest:
- Proteomics of human vitreous to investigate mechanisms underlying the variability in anti-VEGF treatment response in neovascular AMD patients
Vanderbilt University Medical Center
FY2023$175,000R21EY034313 - Proteomics of human vitreous to investigate mechanisms underlying the variability in anti-VEGF treatment response in neovascular AMD patients
Vanderbilt University Medical Center
FY2022$306,250R21EY034313
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Plasma Arginine and Citrulline are Elevated in Diabetic Retinopathy
American Journal of Ophthalmology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Sylvia Groth, MD
Vanderbilt Health
Narender Annapureddy, MD
Vanderbilt Health
Etoi Garrison, MD
Vanderbilt Health
Lealani Acosta, MD
Vanderbilt Health
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Richard Spaide, MD
Vitreous Retina Macula Consultants of New York
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”